Read on Twitter
$ATNM DD thread:
I’m going to leave some links below so you can research for your self as well.
https://www.actiniumpharma.com/product-pipeline/iomab-b
https://www.actiniumpharma.com/product-pipeline
https://www.actiniumpharma.com/awe-technology
https://www.actiniumpharma.com/product-pipeline/iomab-b
https://www.actiniumpharma.com/product-pipeline
https://www.actiniumpharma.com/awe-technology
This video is big time. Watch this!!
Iomab-B is the main reason I’m here!
So usually to go to transplant you have to be in remission. With this drug you’ll be able to transplant without having to be in remission.
Iomab-B was developed at the Fred Hutchinson Cancer Research Center where it has been studied in several Phase 1 and Phase 2 trials in almost 300 patients in a number of blood cancer indications, including acute myeloid leukemia (AML), chronic myeloid leukemia (CML),
Acute lymphoblastic leukemia (ALL), chronic lymphocytic leukemia (CLL), Hodgkin's disease (HD), Non-Hodgkin lymphomas (NHL) and multiple myeloma (MM) and is currently being studied in several ongoing physician trials.
In a Phase 2 clinical study in 58 patients with advanced AML or high-risk myelodysplastic syndrome (MDS) age 50 and older, Iomab-B produced complete remissions in 100% of patients and these patients experienced transplant engraftment at day 28.
They have a webinar in a week and a half to talk about their midpoint results for their phase three trial.
This is a longer swing play.. Actuslly should have news released in the next month or so from the patent that were found.
This is a longer swing play.. Actuslly should have news released in the next month or so from the patent that were found.
Patent is directed to therapeutic compositions comprising radio-labelled monoclonal antibodies. Issue date is 8/11..
That is the drug I’m most focused on! But their pipeline is crazy!!! This is extremely undervalued and a long swing play for me.
